These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 17071614)
41. Overlapping binding sites in protein phosphatase 2A for association with regulatory A and alpha-4 (mTap42) subunits. Prickett TD; Brautigan DL J Biol Chem; 2004 Sep; 279(37):38912-20. PubMed ID: 15252037 [TBL] [Abstract][Full Text] [Related]
43. Molecular cloning and characterization of three beta-defensins from canine testes. Sang Y; Ortega MT; Blecha F; Prakash O; Melgarejo T Infect Immun; 2005 May; 73(5):2611-20. PubMed ID: 15845463 [TBL] [Abstract][Full Text] [Related]
44. Molecular Characterization and In Silico Analysis of Defensin From Tor putitora (Hamilton). Chaturvedi P; Dhanik M; Pande A Probiotics Antimicrob Proteins; 2015 Sep; 7(3):207-15. PubMed ID: 26162426 [TBL] [Abstract][Full Text] [Related]
45. Different dynamics and pathway of disulfide bonds reduction of two human defensins, a molecular dynamics simulation study. Zhang L Proteins; 2017 Apr; 85(4):665-681. PubMed ID: 28106297 [TBL] [Abstract][Full Text] [Related]
46. Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins. Schulz A; Klüver E; Schulz-Maronde S; Adermann K Biopolymers; 2005; 80(1):34-49. PubMed ID: 15625724 [TBL] [Abstract][Full Text] [Related]
47. Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids. Xie C; Prahl A; Ericksen B; Wu Z; Zeng P; Li X; Lu WY; Lubkowski J; Lu W J Biol Chem; 2005 Sep; 280(38):32921-9. PubMed ID: 15894545 [TBL] [Abstract][Full Text] [Related]
48. Defensin like peptide from Panulirus argus relates structurally with beta defensin from vertebrates. Montero-Alejo V; Acosta-Alba J; Perdomo-Morales R; Perera E; Hernández-Rodríguez EW; Estrada MP; Porto-Verdecia M Fish Shellfish Immunol; 2012 Oct; 33(4):872-9. PubMed ID: 22885029 [TBL] [Abstract][Full Text] [Related]
49. Preparation of isotopically labelled recombinant beta-defensin for NMR studies. Seo ES; Vargues T; Clarke DJ; Uhrín D; Campopiano DJ Protein Expr Purif; 2009 Jun; 65(2):179-84. PubMed ID: 19063971 [TBL] [Abstract][Full Text] [Related]
50. Identification and Biological Characterization of Mouse beta-defensin 14, the orthologue of human beta-defensin 3. Röhrl J; Yang D; Oppenheim JJ; Hehlgans T J Biol Chem; 2008 Feb; 283(9):5414-9. PubMed ID: 18167348 [TBL] [Abstract][Full Text] [Related]
51. Monoclonal antibodies recognizing surface residues of the beta subunit of Escherichia coli F(1) ATPase: functional importance of the epitope residues. Kamauchi S; Fudemoto T; Miki J; Inoue H; Kanazawa H J Biochem; 2000 Oct; 128(4):629-35. PubMed ID: 11011145 [TBL] [Abstract][Full Text] [Related]
52. The NMR structure of human beta-defensin-2 reveals a novel alpha-helical segment. Sawai MV; Jia HP; Liu L; Aseyev V; Wiencek JM; McCray PB; Ganz T; Kearney WR; Tack BF Biochemistry; 2001 Apr; 40(13):3810-6. PubMed ID: 11300761 [TBL] [Abstract][Full Text] [Related]
53. Structural elements of the amino-terminal head domain of vimentin essential for intermediate filament formation in vivo and in vitro. Beuttenmüller M; Chen M; Janetzko A; Kühn S; Traub P Exp Cell Res; 1994 Jul; 213(1):128-42. PubMed ID: 8020583 [TBL] [Abstract][Full Text] [Related]
54. Impact of pro segments on the folding and function of human neutrophil alpha-defensins. Wu Z; Li X; Ericksen B; de Leeuw E; Zou G; Zeng P; Xie C; Li C; Lubkowski J; Lu WY; Lu W J Mol Biol; 2007 Apr; 368(2):537-49. PubMed ID: 17355880 [TBL] [Abstract][Full Text] [Related]
55. Use of molecular simulation for mapping conformational CYP2E1 epitopes. Vidali M; Hidestrand M; Eliasson E; Mottaran E; Reale E; Rolla R; Occhino G; Albano E; Ingelman-Sundberg M J Biol Chem; 2004 Dec; 279(49):50949-55. PubMed ID: 15456790 [TBL] [Abstract][Full Text] [Related]
56. Influence of disulfide bonds in human beta defensin-3 on its strain specific activity against Gram-negative bacteria. Nehls C; Böhling A; Podschun R; Schubert S; Grötzinger J; Schromm A; Fedders H; Leippe M; Harder J; Kaconis Y; Gronow S; Gutsmann T Biochim Biophys Acta Biomembr; 2020 Aug; 1862(8):183273. PubMed ID: 32171739 [TBL] [Abstract][Full Text] [Related]
57. Directed mutagenesis in region 713-720 of human thyroperoxidase assigns 713KFPED717 residues as being involved in the B domain of the discontinuous immunodominant region recognized by human autoantibodies. Bresson D; Pugnière M; Roquet F; Rebuffat SA; N-Guyen B; Cerutti M; Guo J; McLachlan SM; Rapoport B; Estienne V; Ruf J; Chardès T; Péraldi-Roux S J Biol Chem; 2004 Sep; 279(37):39058-67. PubMed ID: 15150267 [TBL] [Abstract][Full Text] [Related]
58. Modification of β-Defensin-2 by Dicarbonyls Methylglyoxal and Glyoxal Inhibits Antibacterial and Chemotactic Function In Vitro. Kiselar JG; Wang X; Dubyak GR; El Sanadi C; Ghosh SK; Lundberg K; Williams WM PLoS One; 2015; 10(8):e0130533. PubMed ID: 26244639 [TBL] [Abstract][Full Text] [Related]
59. Defensin-neurotoxin dyad in a basally branching metazoan sea anemone. Kim CH; Lee YJ; Go HJ; Oh HY; Lee TK; Park JB; Park NG FEBS J; 2017 Oct; 284(19):3320-3338. PubMed ID: 28796463 [TBL] [Abstract][Full Text] [Related]
60. Identification of a novel endoplasmic reticulum export motif within the eighth α-helical domain (α-H8) of the human prostacyclin receptor. Donnellan PD; Kimbembe CC; Reid HM; Kinsella BT Biochim Biophys Acta; 2011 Apr; 1808(4):1202-18. PubMed ID: 21223948 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]